APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Narcotics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Opioid Narcotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchOpioid Narcotics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Narcotics Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Opioid Narcotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Narcotics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Narcotics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Opioid Narcotics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Opioid Narcotics include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Opioid Narcotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Narcotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Narcotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Narcotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Narcotics Segment by Company

Yichang Renfu Pharmaceutical Co., Ltd.

Jiangsu Enhua Pharmaceutical Co., Ltd.

Henan Lingrui Pharmaceutical Co., Ltd.

Sinopharm Group Industrial Co., Ltd. Langfang Branch

Changzhou Siyao Pharmaceutical Co., Ltd.

Reig Jofre

Pfizer

GSK

Fresenius Kabi

Daiichi Sankyo

AcelRx Pharmaceuticals, Inc

Abbott

Opioid Narcotics Segment by Type

Fentanyl

Remifentanil

Sufentanil

Opioid Narcotics Segment by Application

Hospital

Clinic

Other

Opioid Narcotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Narcotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Opioid Narcotics Industry Trends Table 2. Opioid Narcotics Industry Drivers Table 3. Opioid Narcotics Industry Opportunities and Challenges Table 4. Opioid Narcotics Industry Restraints Table 5. Global Opioid Narcotics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Opioid Narcotics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Opioid Narcotics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Opioid Narcotics Sales Market Share by Manufacturers Table 9. Global Opioid Narcotics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Opioid Narcotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Opioid Narcotics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Opioid Narcotics Manufacturers, Product Type & Application Table 13. Global Opioid Narcotics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioid Narcotics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Fentanyl Table 17. Major Manufacturers of Remifentanil Table 18. Major Manufacturers of Sufentanil Table 19. Global Opioid Narcotics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Opioid Narcotics Sales by Type (2021-2026) & (K Units) Table 21. Global Opioid Narcotics Sales by Type (2027-2032) & (K Units) Table 22. Global Opioid Narcotics Sales Market Share by Type (2021-2026) Table 23. Global Opioid Narcotics Sales Market Share by Type (2027-2032) Table 24. Global Opioid Narcotics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Opioid Narcotics Revenue by Type (2021-2026) & (K Units) Table 26. Global Opioid Narcotics Revenue by Type (2027-2032) & (K Units) Table 27. Global Opioid Narcotics Revenue Market Share by Type (2021-2026) Table 28. Global Opioid Narcotics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global Opioid Narcotics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Opioid Narcotics Sales by Application (2021-2026) & (K Units) Table 34. Global Opioid Narcotics Sales by Application (2027-2032) & (K Units) Table 35. Global Opioid Narcotics Sales Market Share by Application (2021-2026) Table 36. Global Opioid Narcotics Sales Market Share by Application (2027-2032) Table 37. Global Opioid Narcotics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Opioid Narcotics Revenue by Application (2021-2026) & (K Units) Table 39. Global Opioid Narcotics Revenue by Application (2027-2032) & (K Units) Table 40. Global Opioid Narcotics Revenue Market Share by Application (2021-2026) Table 41. Global Opioid Narcotics Revenue Market Share by Application (2027-2032) Table 42. Global Opioid Narcotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Opioid Narcotics Sales by Region (2021-2026) & (K Units) Table 44. Global Opioid Narcotics Sales Market Share by Region (2021-2026) Table 45. Global Opioid Narcotics Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Opioid Narcotics Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 49. North America Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 50. Europe Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 52. Europe Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 59. Global Opioid Narcotics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Opioid Narcotics Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Opioid Narcotics Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Opioid Narcotics Revenue Market Share by Region (2021-2026) Table 63. Global Opioid Narcotics Revenue Market Share by Region (2027-2032) Table 64. Yichang Renfu Pharmaceutical Co., Ltd. Company Information Table 65. Yichang Renfu Pharmaceutical Co., Ltd. Business Overview Table 66. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 68. Yichang Renfu Pharmaceutical Co., Ltd. Recent Development Table 69. Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information Table 70. Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview Table 71. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 73. Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Development Table 74. Henan Lingrui Pharmaceutical Co., Ltd. Company Information Table 75. Henan Lingrui Pharmaceutical Co., Ltd. Business Overview Table 76. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 78. Henan Lingrui Pharmaceutical Co., Ltd. Recent Development Table 79. Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information Table 80. Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview Table 81. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio Table 83. Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Development Table 84. Changzhou Siyao Pharmaceutical Co., Ltd. Company Information Table 85. Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview Table 86. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 88. Changzhou Siyao Pharmaceutical Co., Ltd. Recent Development Table 89. Reig Jofre Company Information Table 90. Reig Jofre Business Overview Table 91. Reig Jofre Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Reig Jofre Opioid Narcotics Product Portfolio Table 93. Reig Jofre Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Pfizer Opioid Narcotics Product Portfolio Table 98. Pfizer Recent Development Table 99. GSK Company Information Table 100. GSK Business Overview Table 101. GSK Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. GSK Opioid Narcotics Product Portfolio Table 103. GSK Recent Development Table 104. Fresenius Kabi Company Information Table 105. Fresenius Kabi Business Overview Table 106. Fresenius Kabi Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Fresenius Kabi Opioid Narcotics Product Portfolio Table 108. Fresenius Kabi Recent Development Table 109. Daiichi Sankyo Company Information Table 110. Daiichi Sankyo Business Overview Table 111. Daiichi Sankyo Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Daiichi Sankyo Opioid Narcotics Product Portfolio Table 113. Daiichi Sankyo Recent Development Table 114. AcelRx Pharmaceuticals, Inc Company Information Table 115. AcelRx Pharmaceuticals, Inc Business Overview Table 116. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio Table 118. AcelRx Pharmaceuticals, Inc Recent Development Table 119. Abbott Company Information Table 120. Abbott Business Overview Table 121. Abbott Opioid Narcotics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Abbott Opioid Narcotics Product Portfolio Table 123. Abbott Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Opioid Narcotics Distributors List Table 127. Opioid Narcotics Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Opioid Narcotics Product Image Figure 2. Global Opioid Narcotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Narcotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioid Narcotics Sales (2021-2032) & (K Units) Figure 5. Global Opioid Narcotics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Opioid Narcotics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Fentanyl Image Figure 9. Remifentanil Image Figure 10. Sufentanil Image Figure 11. Global Opioid Narcotics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Opioid Narcotics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Opioid Narcotics Sales Market Share by Type (2021-2032) Figure 14. Global Opioid Narcotics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Opioid Narcotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Opioid Narcotics Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Opioid Narcotics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Opioid Narcotics Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Opioid Narcotics Sales Market Share by Application (2021-2032) Figure 23. Global Opioid Narcotics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Opioid Narcotics Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Opioid Narcotics Revenue Market Share by Application (2021-2032) Figure 26. North America Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 28. U.S. Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 33. Germany Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 40. China Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Opioid Narcotics Sales Market Share by Country (2021-2032) Figure 48. Brazil Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Opioid Narcotics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Opioid Narcotics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Opioid Narcotics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Opioid Narcotics Revenue (2021-2032) & (US$ Million) Figure 59. North America Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Opioid Narcotics Revenue (2021-2032) & (US$ Million) Figure 61. Europe Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Opioid Narcotics Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Opioid Narcotics Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Opioid Narcotics Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Opioid Narcotics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl
  • Remifentanil
  • Sufentanil
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yichang Renfu Pharmaceutical Co., Ltd.
  • Jiangsu Enhua Pharmaceutical Co., Ltd.
  • Henan Lingrui Pharmaceutical Co., Ltd.
  • Sinopharm Group Industrial Co., Ltd. Langfang Branch
  • Changzhou Siyao Pharmaceutical Co., Ltd.
  • Reig Jofre
  • Pfizer
  • GSK
  • Fresenius Kabi
  • Daiichi Sankyo
  • AcelRx Pharmaceuticals, Inc
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Opioid Narcotics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Opioid Narcotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Opioid Narcotics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Opioid Narcotics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Opioid Narcotics Market Dynamics
  1. 2.1 Opioid Narcotics Industry Trends
  2. 2.2 Opioid Narcotics Industry Drivers
  3. 2.3 Opioid Narcotics Industry Opportunities and Challenges
  4. 2.4 Opioid Narcotics Industry Restraints
3 Opioid Narcotics Market by Manufacturers
  1. 3.1 Global Opioid Narcotics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Opioid Narcotics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Opioid Narcotics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Opioid Narcotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioid Narcotics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Opioid Narcotics Manufacturers, Product Type & Application
  7. 3.7 Global Opioid Narcotics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioid Narcotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioid Narcotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioid Narcotics Tier 1, Tier 2, and Tier 3
4 Opioid Narcotics Market by Type
  1. 4.1 Opioid Narcotics Type Introduction
  2. 4.1.1 Fentanyl
  3. 4.1.2 Remifentanil
  4. 4.1.3 Sufentanil
  5. 4.2 Global Opioid Narcotics Sales by Type
  6. 4.2.1 Global Opioid Narcotics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Opioid Narcotics Sales by Type (2021-2032)
  8. 4.2.3 Global Opioid Narcotics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Opioid Narcotics Revenue by Type
  10. 4.3.1 Global Opioid Narcotics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Opioid Narcotics Revenue by Type (2021-2032)
  12. 4.3.3 Global Opioid Narcotics Revenue Market Share by Type (2021-2032)
5 Opioid Narcotics Market by Application
  1. 5.1 Opioid Narcotics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Opioid Narcotics Sales by Application
  6. 5.2.1 Global Opioid Narcotics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioid Narcotics Sales by Application (2021-2032)
  8. 5.2.3 Global Opioid Narcotics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Opioid Narcotics Revenue by Application
  10. 5.3.1 Global Opioid Narcotics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Opioid Narcotics Revenue by Application (2021-2032)
  12. 5.3.3 Global Opioid Narcotics Revenue Market Share by Application (2021-2032)
6 Global Opioid Narcotics Sales by Region
  1. 6.1 Global Opioid Narcotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioid Narcotics Sales by Region (2021-2032)
  3. 6.2.1 Global Opioid Narcotics Sales by Region (2021-2026)
  4. 6.2.2 Global Opioid Narcotics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Opioid Narcotics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Opioid Narcotics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Opioid Narcotics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Opioid Narcotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Opioid Narcotics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Opioid Narcotics Revenue by Region
  1. 7.1 Global Opioid Narcotics Revenue by Region
  2. 7.1.1 Global Opioid Narcotics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Opioid Narcotics Revenue by Region (2021-2026)
  4. 7.1.3 Global Opioid Narcotics Revenue by Region (2027-2032)
  5. 7.1.4 Global Opioid Narcotics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Opioid Narcotics Revenue (2021-2032)
  8. 7.2.2 North America Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Opioid Narcotics Revenue (2021-2032)
  11. 7.3.2 Europe Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Opioid Narcotics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Opioid Narcotics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Opioid Narcotics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yichang Renfu Pharmaceutical Co., Ltd.
  2. 8.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  6. 8.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
  8. 8.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  12. 8.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Henan Lingrui Pharmaceutical Co., Ltd.
  14. 8.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  18. 8.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
  20. 8.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
  21. 8.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
  22. 8.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
  24. 8.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
  25. 8.5 Changzhou Siyao Pharmaceutical Co., Ltd.
  26. 8.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  30. 8.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Reig Jofre
  32. 8.6.1 Reig Jofre Company Information
  33. 8.6.2 Reig Jofre Business Overview
  34. 8.6.3 Reig Jofre Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Reig Jofre Opioid Narcotics Product Portfolio
  36. 8.6.5 Reig Jofre Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Opioid Narcotics Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Opioid Narcotics Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Fresenius Kabi
  50. 8.9.1 Fresenius Kabi Company Information
  51. 8.9.2 Fresenius Kabi Business Overview
  52. 8.9.3 Fresenius Kabi Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
  54. 8.9.5 Fresenius Kabi Recent Developments
  55. 8.10 Daiichi Sankyo
  56. 8.10.1 Daiichi Sankyo Company Information
  57. 8.10.2 Daiichi Sankyo Business Overview
  58. 8.10.3 Daiichi Sankyo Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
  60. 8.10.5 Daiichi Sankyo Recent Developments
  61. 8.11 AcelRx Pharmaceuticals, Inc
  62. 8.11.1 AcelRx Pharmaceuticals, Inc Company Information
  63. 8.11.2 AcelRx Pharmaceuticals, Inc Business Overview
  64. 8.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
  66. 8.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
  67. 8.12 Abbott
  68. 8.12.1 Abbott Company Information
  69. 8.12.2 Abbott Business Overview
  70. 8.12.3 Abbott Opioid Narcotics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abbott Opioid Narcotics Product Portfolio
  72. 8.12.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioid Narcotics Value Chain Analysis
  2. 9.1.1 Opioid Narcotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioid Narcotics Production Mode & Process
  6. 9.2 Opioid Narcotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioid Narcotics Distributors
  9. 9.2.3 Opioid Narcotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst